InfuSystem Holdings, Inc. – AMEX:INFU
InfuSystem Holdings stock price today
$9.47
+1.33
+16.34%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 2 hours
InfuSystem Holdings stock price monthly change
+17.97%
month
InfuSystem Holdings stock price quarterly change
+17.97%
quarter
InfuSystem Holdings stock price yearly change
-25.25%
year
InfuSystem Holdings key metrics
Market Cap | 176.91M |
Enterprise value | 220.09M |
P/E | 885 |
EV/Sales | 2.00 |
EV/EBITDA | 14.77 |
Price/Sales | 1.66 |
Price/Book | 3.81 |
PEG ratio | -8.96 |
EPS | N/A |
Revenue | 127.41M |
EBITDA | 15.54M |
Income | 84K |
Revenue Q/Q | 5.35% |
Revenue Y/Y | 12.23% |
Profit margin | 0.02% |
Oper. margin | 1.5% |
Gross margin | 56.93% |
EBIT margin | 1.5% |
EBITDA margin | 12.2% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeInfuSystem Holdings stock price history
InfuSystem Holdings stock forecast
InfuSystem Holdings financial statements
| Jun 2023 | 31.73M | 435K | 1.37% |
|---|---|---|---|
| Sep 2023 | 31.90M | 689K | 2.16% |
| Dec 2023 | 31.77M | 72K | 0.23% |
| Mar 2024 | 31.99M | -1.11M | -3.48% |
| Sep 2025 | 36.7M | 1.95M | 5.34% |
|---|---|---|---|
| Oct 2025 | 36.75M | 1.91M | 5.2% |
| Dec 2025 | 40.7M | 3.60M | 8.87% |
| Mar 2026 | 38.7M | 2.61M | 6.75% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 102749000 | 52.79M | 51.38% |
|---|---|---|---|
| Sep 2023 | 102071000 | 50.60M | 49.58% |
| Dec 2023 | 109885000 | 57.58M | 52.4% |
| Mar 2024 | 104850000 | 52.57M | 50.14% |
| Jun 2023 | 2.45M | -2.33M | -235K |
|---|---|---|---|
| Sep 2023 | 4.26M | -300K | -3.93M |
| Dec 2023 | 4.42M | -1.04M | -3.31M |
| Mar 2024 | 377K | -418K | 632K |
InfuSystem Holdings alternative data
| Aug 2023 | 420 |
|---|---|
| Sep 2023 | 420 |
| Oct 2023 | 420 |
| Nov 2023 | 420 |
| Dec 2023 | 420 |
| Jan 2024 | 420 |
| Feb 2024 | 420 |
| Mar 2024 | 420 |
| Apr 2024 | 420 |
| May 2024 | 499 |
| Jun 2024 | 499 |
| Jul 2024 | 499 |
InfuSystem Holdings other data
52.90%
-1.06%
of INFU is owned by hedge funds
11.34M
+241.18K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| May 2024 | 18300 | 0 |
| Sep 2024 | 4000 | 0 |
| Nov 2024 | 0 | 40000 |
| Patent |
|---|
Application Filling date: 15 May 2019 Issue date: 19 Nov 2020 |
| Quarter | Transcript |
|---|---|
| Q1 2024 9 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 14 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 7 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 4 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Mr. Richard A. DiIorio (1975) Chief Executive Officer & Director | $1,060,000 |
| Mr. Barry G. Steele (1971) Executive Vice President & Chief Financial Officer | $475,120 |
Ms. Carrie Lachance B.S.N., M.B.A., R.N. (1977) Pres, Chief Operating Officer & Director | $468,250 |
Sanara MedTech: Surgical Sales Set To Accelerate While Post Acute Care Platform Develops
InfuSystem: Disappointing 2022 Results Lead To Bargain Prices
My Top Small-Cap Ideas For 2023
InfuSystem Business Is Back On Track
InfuSystem: A Possible Goldmine After Recent Stumble
January Correction Leads To Attractive Opportunities
Weather Cooling Down, But InfuSystem Heating Up
InfuSystem: Looking Beyond The Headline Numbers
-
What's the price of InfuSystem Holdings stock today?
One share of InfuSystem Holdings stock can currently be purchased for approximately $9.47.
-
When is InfuSystem Holdings's next earnings date?
Unfortunately, InfuSystem Holdings's (INFU) next earnings date is currently unknown.
-
Does InfuSystem Holdings pay dividends?
No, InfuSystem Holdings does not pay dividends.
-
How much money does InfuSystem Holdings make?
InfuSystem Holdings has a market capitalization of 176.91M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 14.44% to 125.79M US dollars.
-
What is InfuSystem Holdings's stock symbol?
InfuSystem Holdings, Inc. is traded on the AMEX under the ticker symbol "INFU".
-
What is InfuSystem Holdings's primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of InfuSystem Holdings?
Shares of InfuSystem Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are InfuSystem Holdings's key executives?
InfuSystem Holdings's management team includes the following people:
- Mr. Richard A. DiIorio Chief Executive Officer & Director(age: 50, pay: $1,060,000)
- Mr. Barry G. Steele Executive Vice President & Chief Financial Officer(age: 54, pay: $475,120)
- Ms. Carrie Lachance B.S.N., M.B.A., R.N. Pres, Chief Operating Officer & Director(age: 48, pay: $468,250)
-
How many employees does InfuSystem Holdings have?
As Jul 2024, InfuSystem Holdings employs 499 workers, which is 19% more then previous quarter.
-
When InfuSystem Holdings went public?
InfuSystem Holdings, Inc. is publicly traded company for more then 17 years since IPO on 27 Dec 2007.
-
What is InfuSystem Holdings's official website?
The official website for InfuSystem Holdings is infusystem.com.
-
Where are InfuSystem Holdings's headquarters?
InfuSystem Holdings is headquartered at 3851 West Hamlin Road, Rochester Hills, MI.
-
How can i contact InfuSystem Holdings?
InfuSystem Holdings's mailing address is 3851 West Hamlin Road, Rochester Hills, MI and company can be reached via phone at +248 2 911 210.
InfuSystem Holdings company profile:
InfuSystem Holdings, Inc.
infusystem.comExchange:
AMEX
Full time employees:
499
Industry:
Medical - Instruments & Supplies
Sector:
Healthcare
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
3851 West Hamlin Road
Rochester Hills, MI 48309
Rochester Hills, MI 48309
CIK: 0001337013
ISIN: US45685K1025
CUSIP: 45685K102
